Increased numbers of CD8+ T cells in lung tissue from IPF patients was associated with worse pulmonary outcomes [130], and in BAL fluid, higher CD4/CD8 ratios correlated with an improved clinical response to anti-inflammatory therapy [133]. The gene discussed is CD4; the disease is idiopathic pulmonary fibrosis.